Relative Bioavailability of 2 Oral Formulations of Nintedanib
Clinical trial NCT02572752 · COMPLETED
Trial details
- NCT number
- NCT02572752
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2015-11-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.